About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-ND5
A12397G
A12397G-F1
A12770G
A12955G
A12955G-F1
A13045C
A13045G
A13045G-F1
A13084T
A13084T-F1
A13379C
A13379G
A13379G-F1
A13511T
A13514G
A13514G-F5
A13528G
A13528G-F6
A13528G-F5
A13528G-F4
A13528G-F2
A13528G-F1
A13615G
A13637G
A13637G-F1
A13849C
A13849C-F1
A14091T
A14091T-F1
C12350A
C12848T
C12848T-F1
C13565T
C13565T-F1
G12814T
G13042A
G13042A-F3
G13042A-F2
G13051A
G13051A-F3
G13051A-F2
G13063A
G13063A-F1
G13135A
G13135A-F3
G13135A-F2
G13135A-F1
G13138A
G13138A-F1
G13204A
G13513A
G13513A-F74
G13513A-F70
G13513A-F69
G13513A-F60
G13513A-F55
G13513A-F51
G13513A-F48
G13513A-F13
G13513A-F11
G13513A-F10
G13513A-F9
G13513A-F8
G13513A-F6
G13513A-F1
G13730A
T12477C
T12631A
T12706C
T12706C-F6
T12782G
T12811C
T13046C
T13091C
T13091C-F1
T13094C
T13094C-F14
T13094C-F13
T13094C-F10
T13094C-F9
T13094C-F8
T13094C-F7
T13094C-F6
T13271C
T13271C-F1
T13340C
T13376C
T13376C-F1
T14063C
Edit by Mitofam Team
-
+
首页
T13091C
# **General Information** | **Position** | **13091** | **Variant** | **m.13091T\>C** | **Locus** | **MT\-ND5** | **Amino\-AcidChange** | **M252T** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **APOGEE2** | Pathogenic | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.13091T\>C** variant in MT\-ND5 has been reported in 1 pedigree. To date, 2 carriers have been reported. Reported mutation loads ranged from 4% to 61%, with a median of 30% overall; affected carriers showed mutation loads from 4% to 61%, with a median of 30%. In one affected carrier, a marked tissue\-specific difference was observed, with higher mutation loads in muscle (61%), urine (52%), hair (12%), and bone marrow (30%) than in blood (4%). The main clinical manifestations among affected carriers included MELAS, migraine, and repeated migraine attacks. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 13091 | m.13091T\>C | [T13091C\-F1](https://mitofam.com/doc/1375/) | Czech Republic | MELAS | 0 | 1 | 2020 | [31996177](https://pubmed.ncbi.nlm.nih.gov/31996177/) | P8 family; Table 1 and maternal testing text.; Czech Republic inferred from Czech diagnostic center and patient cohort context. | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 13091 | m.13091T\>C | T13091C\-F1 | T13091C\-F1\-II1 | Fam | ND | Y | Y | A | onset 10 y; alive 31 y | 4% | 61% | 52% | 12%(H); 30%(BM) | Migraine; MELAS | Table 1\.; Source: P8 | | 2 | 13091 | m.13091T\>C | T13091C\-F1 | T13091C\-F1\-I2 | Fam | F | N | Y | A | ND | / | / | / | Positive(ND) | Repeated migraine attacks | Maternal testing paragraph.; Source: P8 mother | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月30日 03:04
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)